Affordable Access

Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.

Authors
  • Zilly, M
  • Lingenauber, C
  • Desch, S
  • Väth, T
  • Klinker, H
  • Langmann, P
Type
Published Article
Journal
European journal of medical research
Publication Date
Apr 30, 2002
Volume
7
Issue
4
Pages
149–154
Identifiers
PMID: 12010649
Source
Medline
License
Unknown

Abstract

In patients with a breakthrough or relapse after interferon monotherapy or standard combination therapy with interferon and ribavirin a re-therapy with a triple combination of interferon, ribavirin, and amantadine results in a high rate of sustained virological response.

Report this publication

Statistics

Seen <100 times